Kronenfeld Mark A.
SEC CIK 1578074 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Dir | 31.1K | — | $555.6K | 7 | 2022-06-08 | 2025-06-11 |
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
Kronenfeld Mark A. made no open-market trades at PCRX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-03-19 | 2025-06-11 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +6,163 | 31.1K | +25% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +9,999 | 34.9K | +40% | $0 |
| D | 2024-06-13 | 2024-06-12 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +5,230 | 24.9K | +27% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +1,775 | 19.7K | +10% | $0 |
| D | 2023-06-12 | 2023-06-08 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | M - OptEx | $29.90 | +15.0K | 32.9K | +84% | +$448.5K |
| D | 2023-06-12 | 2023-06-08 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | S - Sale+OE | $37.04 | -15.0K | 17.9K | -46% | -$555.6K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +1,160 | 17.9K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations